CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating Expenses [Abstract]
Research and development	$ 17,722	$ 20,540	$ 57,517	$ 51,826
General and administrative	5,449	4,240	15,877	12,129
Total operating expenses	23,171	24,780	73,394	63,955
Operating loss	(23,171)	(24,780)	(73,394)	(63,955)
Other income (expense)
Interest income	1,826	1,578	5,682	5,054
Other (expense) income, net	(39)	(88)	(27)	(230)
Total other income, net	1,787	1,490	5,655	4,824
Net loss before income tax	(21,384)	(23,290)	(67,739)	(59,131)
Net loss	$ (21,384)	$ (23,290)	$ (67,739)	$ (59,131)
Net loss per share, basic	$ (0.66)	$ (0.98)	$ (2.17)	$ (2.49)
Net loss per share, diluted	$ (0.66)	$ (0.98)	$ (2.17)	$ (2.49)
Weighted-average common shares outstanding, basic	32,581,542	23,790,430	31,240,622	23,788,950
Weighted-average common shares outstanding, diluted	32,581,542	23,790,430	31,240,622	23,788,950
Other comprehensive (loss) income:
Cumulative translation adjustment arising during the period	$ (20)	$ (70)	$ (72)	$ 24
Unrealized gain on marketable securities	186		129
Comprehensive loss	$ (21,218)	$ (23,360)	$ (67,682)	$ (59,107)